Snore Formula 86% Effectiveness Claim Put To Rest By FTC
This article was originally published in The Tan Sheet
Executive Summary
Claims that Dr. Harris' Original Snore Formula significantly reduces snoring in 86% of users are not adequately supported by scientific data, FTC states in an April 15 1consent agreement
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning